Lv1
28 积分 2024-01-27 加入
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
17小时前
待确认
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
1个月前
已完结
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD
2个月前
已完结
Liver fibrosis stage based on the four factors (FIB-4) score or Forns index in adults with chronic hepatitis C
4个月前
已完结
Natural History and Predictors of Clinical Outcomes in Autoimmune Liver Diseases: A Multicenter Study
4个月前
已完结
Serum Fibrosis Tests Guide Prognosis in Metabolic Dysfunction–Associated Fatty Liver Disease Patients Referred From Primary Care
4个月前
已完结
Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD
4个月前
已完结
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
4个月前
已完结
The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease
4个月前
已完结
Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus
4个月前
已完结
皖公网安备34019202002308
